Literature DB >> 22749683

Dopamine agonist withdrawal syndrome in a patient with restless legs syndrome.

Benjamin J Dorfman, Melissa J Nirenberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22749683     DOI： 10.1016/j.parkreldis.2012.06.006

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN： 1353-8020            Impact factor:   4.891


× No keyword cloud information.
  3 in total

1.  Dopamine agonist withdrawal syndrome in a patient with restless legs syndrome without impulse control disorder or drug abuse.

Authors:  Yasushi Shimo; Asuka Nakajima; Nobutaka Hattori
Journal:  Neurol Sci       Date:  2014-11-02       Impact factor: 3.307

2.  Increased Risk for New-Onset Psychiatric Adverse Events in Patients With Newly Diagnosed Primary Restless Legs Syndrome Who Initiate Treatment With Dopamine Agonists: A Large-Scale Retrospective Claims Matched-Cohort Analysis.

Authors:  Cheryl Hankin; Daniel Lee; Diego Garcia-Borreguero; Zhaohui Wang
Journal:  J Clin Sleep Med       Date:  2019-09-15       Impact factor: 4.062

Review 3.  Dopamine agonist withdrawal syndrome: implications for patient care.

Authors:  Melissa J Nirenberg
Journal:  Drugs Aging       Date:  2013-08       Impact factor: 3.923
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.